From vaccines to AI: New weapons in the fight against cancer
Could humanity finally be gaining the upper hand in our age-old fight against cancer?
Feb 2, 2023
0
22
Could humanity finally be gaining the upper hand in our age-old fight against cancer?
Feb 2, 2023
0
22
Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients. These findings support recommending vaccination for patients ...
Jan 31, 2023
0
10
A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy and resulted in new treatment strategies.
Jan 26, 2023
0
61
Cancer experts have tried, sometimes unsuccessfully, to use the total number of mutations in a tumor, called the tumor mutation burden (TMB), to predict a patient's response to immunotherapy. Now, investigators at the Johns ...
Jan 26, 2023
0
36
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has identified an unexpected driver of cancer immunotherapy resistance: the harmful effect of chronic Type I Interferon signaling on tumor-killing ...
Jan 26, 2023
0
51
Researchers from the University of Michigan Rogel Cancer Center have found a mechanism for why a subset of patients' tumors grow, rather than shrink, when faced with immunotherapy.
Jan 18, 2023
0
40
Removing a single protein from cells that surround tumors can improve the sensitivity of certain cancers to immunotherapy, researchers have found.
Jan 9, 2023
0
10
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40
In a retrospective study, a team of researchers from several health care systems and universities, including Emory University, has discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging ...
Jan 5, 2023
0
70
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor ...
Dec 30, 2022
0
124